Capecitabine Arrow 150mg film-coated Tablets Malta - English - Medicines Authority

capecitabine arrow 150mg film-coated tablets

arrow generics limited whiddon valley barnstaple, north devon, ex32 8ns, united kingdom - capecitabine - film-coated tablet - capecitabine 150 mg - antineoplastic agents

Capecitabine Arrow 500mg film-coated Tablets Malta - English - Medicines Authority

capecitabine arrow 500mg film-coated tablets

arrow generics limited whiddon valley barnstaple, north devon, ex32 8ns, united kingdom - capecitabine - film-coated tablet - capecitabine 500 mg - antineoplastic agents

Capecitabine Fresenius Kabi 150mg Malta - English - Medicines Authority

capecitabine fresenius kabi 150mg

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - capecitabine - film-coated tablet - capecitabine 150 mg - antineoplastic agents

Capecitabine Fresenius Kabi 500mg Malta - English - Medicines Authority

capecitabine fresenius kabi 500mg

fresenius kabi oncology plc lion court, farnham road, bordon, hampshire, gu35 0nf, united kingdom - capecitabine - film-coated tablet - capecitabine 500 mg - antineoplastic agents

Capecitabine Fair-Med 150mg film-coated tablets. United Kingdom - English - myHealthbox

capecitabine fair-med 150mg film-coated tablets.

fair-med healthcare gmbh - capecitabine - film-coated tablets - 150mg - cytostatic (antimetabolite) - capecitabine is indicated for the adjuvant treatment of patients following surgery of stage iii (dukes’ stage c) colon cancer capecitabine is indicated for the treatment of metastatic colorectal cancer capecitabine is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline.

Capecitabine Fair-Med 500mg film-coated tablets. United Kingdom - English - myHealthbox

capecitabine fair-med 500mg film-coated tablets.

fair-med healthcare gmbh - capecitabine - film-coated tablets - 500mg - cytostatic (antimetabolite) - capecitabine is indicated for the adjuvant treatment of patients following surgery of stage iii (dukes’ stage c) colon cancer capecitabine is indicated for the treatment of metastatic colorectal cancer capecitabine is indicated for first-line treatment of advanced gastric cancer in combination with a platinum-based regimen capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic chemotherapy. previous therapy should have included an anthracycline.

CAPECITABINE APOTEX capecitabine 500 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

capecitabine apotex capecitabine 500 mg tablet blister pack

apotex pty ltd - capecitabine -

Capecitabine Sandoz 150mg film-coated Tablets Malta - English - Medicines Authority

capecitabine sandoz 150mg film-coated tablets

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - capecitabine - film-coated tablet - capecitabine 150 mg - antineoplastic agents

Capecitabine Sandoz 500mg film-coated Tablets Malta - English - Medicines Authority

capecitabine sandoz 500mg film-coated tablets

sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - capecitabine - film-coated tablet - capecitabine 500 mg - antineoplastic agents

CAPECCORD capecitabine 150 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

capeccord capecitabine 150 mg film-coated tablet blister pack

accord healthcare pty ltd - capecitabine, quantity: 150 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; purified talc; titanium dioxide; lactose; magnesium stearate; purified water; hypromellose; microcrystalline cellulose; iron oxide yellow; iron oxide red - colon cancer:,capecitabine is indicated for the adjuvant treatment of patients with duke?s stage c and highrisk stage b, colon cancer, either as monotherapy or in combination with oxaliplatin.,colorectal cancer:,capecitabine is indicated for the treatment of patients with advanced or metastatic colorectal cancer.,oesophagogastric cancer:,capecitabine is indicated for the first-line treatment of patients with advanced oesophagogastric cancer in combination with a platinum-based regimen.,breast cancer:,capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated.,capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.